Equities

Rainbow Children's Medicare Ltd

RAINBOW:NSI

Rainbow Children's Medicare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,584.85
  • Today's Change8.85 / 0.56%
  • Shares traded106.25k
  • 1 Year change+40.25%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 10:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform3
Hold1
Sell1
Strong Sell0

Share price forecast in INR

The 5 analysts offering 12 month price targets for Rainbow Children's Medicare Ltd have a median target of 1,610.00, with a high estimate of 1,660.00 and a low estimate of 1,240.00. The median estimate represents a 2.09% increase from the last price of 1,577.00.
High5.3%1,660.00
Med2.1%1,610.00
Low-21.4%1,240.00

Dividends

In 2024, Rainbow Children's Medicare Ltd reported a dividend of 3.00 INR, equaling last years dividend. The 4 analysts covering the company expect dividends of 5.12 INR for the upcoming fiscal year, an increase of 70.67%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On Oct 27, 2024, Rainbow Children's Medicare Ltd reported 2nd quarter 2025 earnings of 7.77 per share.
The next earnings announcement is expected on May 19, 2025.
Average growth rate+14.49%
Rainbow Children's Medicare Ltd reported annual 2024 earnings of 21.38 per share on May 19, 2024.
Average growth rate+2.35%
More ▼

Revenue history & estimates in INR

Rainbow Children's Medicare Ltd had 2nd quarter 2025 revenues of 4.17bn. This missed the 4.19bn estimate of the one analyst following the company. This was 28.18% above the prior year's 2nd quarter results.
Average growth rate+6.98%
Rainbow Children's Medicare Ltd had revenues for the full year 2024 of 12.97bn. This was 10.51% above the prior year's results.
Average growth rate+10.51%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.